Author:
Ogasawara Michihiro,Tamura Naoto,Kageyama Michiaki,Onuma Shin,Kusaoi Makio,Toyama Shoko,Sekiya Fumio,Matsudaira Ran,Nawata Masuyuki,Tada Kurisu,Matsushita Masakazu,Kempe Kazuo,Amano Hirofumi,Morimoto Shinji,Yamaji Ken,Takasaki Yoshinari
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Rheumatology
Reference13 articles.
1. Furst D, Saag K, Fleischmann M, Sherrer Y, Block J, Schnitzer T et al (2002) Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: a six-month, double-blind, randomized, dose-ranging study. Arthritis Rheum 46:2020–2028
2. Yocum D, Furst D, Kaine J, Baldassare A, Stevenson J, Borton M et al (2003) Efficacy and safety of tacrolimus in patients with rheumatoid arthritis: a double-blind trial. Arthritis Rheum 48:3328–3337
3. Yocum D, Furst D, Bensen W, Burch F, Borton M, Mengle-Gaw L et al (2004) Safety of tacrolimus in patients with rheumatoid arthritis: long-term experience. Rheumatology (Oxford) 43:992–999
4. Kawai S, Hashimoto H, Kondo H, Murayama T, Kiuchi T, Abe T (2006) Comparison of tacrolimus and mizoribine in a randomized, double-blind controlled study in patients with rheumatoid arthritis. J Rheumatol 33:2153–2161
5. Kawai S, Yamamoto K (2006) Safety of tacrolimus, an immunosuppressive agent, in the treatment of rheumatoid arthritis in elderly patients. Rheumatology (Oxford) 45:441–444
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献